We are live on
!
Find out more
SCS
Syquant Capital SAS Portfolio holdings
AUM
$447M
1-Year Est. Return
13.04%
This Fund
S&P 500
This Quarter
Est. Return
+18.07%
1 Year Est. Return
+13.04%
3 Year Est. Return
+175.6%
5 Year Est. Return
+350.63%
10 Year Est. Return
–
AUM
$63.5M
AUM Growth
+$41.4M
(+187%)
Cap. Flow
+$38.3M
Cap. Flow
% of AUM
60.26%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
13
New
6
Increased
–
Reduced
–
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TCN
Tricon Residential Inc.
TCN
|
+$41.3M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$11.7M |
| 3 |
HOLI
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
|
+$3.31M |
| 4 |
X
US Steel
X
|
+$2.23M |
| 5 |
Macy's
M
|
+$1.71M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$9.04M |
| 2 |
Lazard
LAZ
|
+$7.2M |
| 3 |
ICVX
Icosavax, Inc. Common Stock
ICVX
|
+$3M |
| 4 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$2.57M |
| 5 |
Logitech
LOGI
|
+$129K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 67.96% |
| 2 | Energy | 20.94% |
| 3 | Industrials | 5.19% |
| 4 | Materials | 3.13% |
| 5 | Consumer Discretionary | 2.78% |
Similar funds
PT
FFO
PC
AIS
SCA
FTA
GC
POEH
Syquant Capital SAS's Q1 2024 Portfolio in Review
As of Q1 2024, Syquant Capital SAS held 13 positions worth $63.5M, up 187% from $22.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Syquant Capital SAS deployed $38.3M of net new capital in Q1 2024, opening 6 new positions. Its largest new stake was Tricon Residential Inc.: 3,873,297 shares worth $43.2M.
By sector, the portfolio is most concentrated in Real Estate at 68% of assets, followed by Energy and Industrials.
On the sell side, the most notable exit was Mirati Therapeutics, Inc. Common Stock, an estimated $9.04M sold.
- Syquant Capital SAS's largest Q1 2024 buy was Tricon Residential Inc.: 3,873,297 shares worth $43.2M.
- Syquant Capital SAS fully exited Mirati Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $9.04M.
- Syquant Capital SAS's ten largest holdings make up 100% of its $63.5M portfolio in Q1 2024.
- Syquant Capital SAS opened 6 new positions and closed 7 in Q1 2024.
- Syquant Capital SAS's portfolio value rose 187% quarter-over-quarter to $63.5M.
Based on Syquant Capital SAS's 13F filing for Q1 2024, filed 9 Apr 2024.